Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14433
Articles
Deals
Prenetics Acquires Majority Stake in ACT Genomics to Boost Oncology Services
January 27, 2025
Company
Drug
CStone’s Sugemalimab MAA Accepted by UK MHRA for NSCLC Treatment
January 27, 2025
Company
Drug
Ascletis Pharma Receives USPTO Notice for ASC10 Patent
January 27, 2025
Company
Drug
HutchMed Initiates Rolling NDA Submission for Elunate to US FDA
January 27, 2025
Legal / IP
Policy / Regulatory
PCAOB Report Signals Relief for US-Listed Chinese Biotechs
January 27, 2025
Company
Deals
Luye Pharma’s Shandong Boan Biotechnology IPOs on Hong Kong Stock Exchange
January 27, 2025
Company
Drug
Simcere Pharmaceutical Completes Enrollment for SIM0417 COVID-19 Drug Trial
January 27, 2025
Company
Drug
Neurophth’s NFS-02 Gene Therapy Gets FDA IND Approval for LHON Treatment
January 27, 2025
Company
Drug
TG ImmunoPharma Gains FDA Approval for Phase I Study of Anti-PVRIG Antibody
January 27, 2025
Company
Deals
Adagene Initiates International Study for ADG126 in Hepatocellular Carcinoma
January 27, 2025
Company
Drug
Jiangsu Recbio’s Herpes Zoster Vaccine REC610 Gets Clinical Trial Approval in Philippines
January 27, 2025
Company
Deals
Endo International Licenses TLC’s Phase III Nanomedicine for OA Knee Pain
January 27, 2025
1
2
…
1,068
1,069
1,070
1,071
1,072
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?